These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24146411)

  • 21. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases.
    Sawicka B; Bossowski A; Szalecki M; Wysoka J; Koput A; Zelazowska-Rutkowska B; Tobolczyk J; Rogowski F; Łuba M
    J Pediatr Endocrinol Metab; 2010 Apr; 23(4):345-54. PubMed ID: 20583539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.
    Koornstra JJ; Kerstens MN; Hoving J; Visscher KJ; Schade JH; Gort HB; Leemhuis MP
    Neth J Med; 1999 Nov; 55(5):215-21. PubMed ID: 10593131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
    Grubeck-Loebenstein B; Londei M; Greenall C; Pirich K; Kassal H; Waldhäusl W; Feldmann M
    J Clin Invest; 1988 May; 81(5):1608-14. PubMed ID: 3130398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
    Meller J; Jauho A; Hüfner M; Gratz S; Becker W
    Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the effect of ligation of the inferior thyroid arteries during non-radical thyroidectomy in simple goiter on selected parameters of calcium-phosphate metabolism in the body].
    Kosiński B
    Ann Acad Med Stetin; 1991; 37():179-90. PubMed ID: 1816751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
    Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and classification of Graves' disease.
    Menconi F; Marcocci C; Marinò M
    Autoimmun Rev; 2014; 13(4-5):398-402. PubMed ID: 24424182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of post-partum Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy.
    Hidaka Y; Tamaki H; Iwatani Y; Tada H; Mitsuda N; Amino N
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):15-20. PubMed ID: 7914152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Beta-2-microglobulin in hyperthyroidism].
    Foscolo G; Roiter I; De Menis E; Legovini P; Conte N
    Minerva Endocrinol; 1992; 17(1):1-5. PubMed ID: 1495449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism.
    Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M
    J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management.
    Díez JJ
    Gerontology; 2003; 49(5):316-23. PubMed ID: 12920352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmune thyrotoxicosis: diagnostic challenges.
    Ponto KA; Kahaly GJ
    Am J Med; 2012 Sep; 125(9):S1. PubMed ID: 22938935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.
    Watt T; Cramon P; Bjorner JB; Bonnema SJ; Feldt-Rasmussen U; Gluud C; Gram J; Hansen JL; Hegedüs L; Knudsen N; Bach-Mortensen P; Nolsøe R; Nygaard B; Pociot F; Skoog M; Winkel P; Rasmussen AK
    Trials; 2013 Apr; 14():119. PubMed ID: 23782950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenic study in Graves' disease treated with thyroid arterial embolization.
    Zhao W; Gao BL; Liu ZY; Yi GF; Shen LJ; Yang HY; Li H; Song DP; Jiang YN; Hu JH; Luo G
    Clin Invest Med; 2009 Oct; 32(5):E335-44. PubMed ID: 19796574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of cytokines in children and adolescents with Graves' disease and non-toxic nodular goiter.
    Bossowski A; Urban M
    J Pediatr Endocrinol Metab; 2001 Jun; 14(6):741-7. PubMed ID: 11453524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.